Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 0.511% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] Cc1cccc(OCC(=O)OC2CN3CCC2CC3)c1.Cl
[b] Cc1cc(C)n(-c2nc3sc4c(c3c(=O)[nH]2)CCCC4)n1
[c] O=c1c2ccccc2nc(CNCC2CCCO2)n1-c1ccc(F)cc1
Answer: b. Cc1cc(C)n(-c2nc3sc4c(c3c(=O)[nH]2)CCCC4)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)n(-c2nc3sc4c(c3c(=O)[nH]2)CCCC4)n1
Cc1cc(C)n(-c2nc3sc4c(c3c(=O)[nH]2)CCCC4)n1
2-(3,5-dimethylpyrazol-1-yl)-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-4-one